- Home
- KPTI vs LPRO Comparison
KPTI vs LPRO Comparison
Compare KPTI & LPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KPTI | LPRO |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | 228 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.8M | 198.9M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KPTI | LPRO |
|---|---|---|
| Price | $8.63 | $1.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $16.00 | $2.58 |
| AVG Volume (30 Days) | 403.3K | ★ 595.1K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.46 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | N/A |
| Revenue This Year | N/A | $10.58 |
| Revenue Next Year | $22.36 | $14.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.65 | $1.18 |
| 52 Week High | $10.99 | $2.70 |
Technical Indicators
Market Signals| Indicator | KPTI | LPRO |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 59.05 |
| Support Level | $8.11 | $1.74 |
| Resistance Level | $9.00 | $1.93 |
| Average True Range (ATR) | 0.58 | 0.14 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 33.12 | 68.29 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About LPRO Open Lending Corporation
Open Lending Corp is a provider of lending enablement and risk analytics to credit unions, regional banks, finance companies and the captive finance companies of automakers (OEM captive finance companies). Through its flagship product, LPP, its customers, collectively referred to herein as automotive lenders or lenders, make automotive consumer loans to underserved near-prime and non-prime borrowers by harnessing its risk-based interest rate pricing models, powered by its proprietary data and real-time underwriting of automotive loan default insurance coverage from insurers.